Processa Pharmaceuticals, Inc. · NASDAQ:PCSA

Lin Patrick bought 1,369 Processa Pharmaceuticals, Inc. shares (Form 4)

Traded Apr 15, 2026 · Filed Apr 17, 2026

On Apr 15, 2026, Lin Patrick (Chief Business - Strategy Off) bought 1,369 Processa Pharmaceuticals, Inc. shares at US$2.97 for US$4,066, leaving 4,725 shares. Filed Apr 17, 2026 (Form 4).

Bought
1,369 shares
Price
US$2.97
Value
US$4,066
Holding after
4,725 shares
Trading plan
No
Role
Chief Business - Strategy Off

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 15, 2026Common StockBuy1,369US$2.974,725Direct

Source

View original at SEC

Related